Pyruvate is an oxyradical scavenger. Because it is a normal tissue met
abolite, it can potentially be developed into an anticataract agent. T
his study was done to determine pyruvate's in vivo corneal penetration
and consequent galactose induced cataract prevention. Pyruvate's anti
cataract effects after subcutaneous administration of 0.05 umole pyruv
ate/rat was also evaluated in a selenite model of cataract. The cornea
l penetration of pyruvate was studied after topical application of a 1
5% eye drop preparation in rabbits and by the use of goat cornea in vi
tro. Pyruvate penetration through the cornea in vitro follows a linear
course. Its basal aqueous level was 600+/-50 mu M rising to 1,500+/-3
0 mu M after a single drop, with the half life being 21.6 minutes. Suc
h an application delayed the formation of galactose cataracts, stoppin
g their progression beyond the second stage. Subcutaneous administrati
on of pyruvate provided 75% protection against selenite cataracts as w
ell.